Laura Prendergast
Stock Analyst at Raymond James
(1.54)
# 2,367
Out of 4,496 analysts
4
Total ratings
50%
Success rate
16.8%
Average return
Main Sectors:
Top Industries:
3 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| THRD Third Harmonic Bio | Initiates: Outperform | $18 | $11.81 | +52.41% | 1 | Jun 7, 2024 | |
| RVMD Revolution Medicines | Upgrades: Strong Buy | $36 → $48 | $46.14 | +4.03% | 2 | Apr 10, 2024 | |
| NKTX Nkarta | Downgrades: Outperform | $13 → $16 | $6.21 | +157.65% | 1 | Mar 22, 2024 |
Third Harmonic Bio
Jun 7, 2024
Initiates: Outperform
Price Target: $18
Current: $11.81
Upside: +52.41%
Revolution Medicines
Apr 10, 2024
Upgrades: Strong Buy
Price Target: $36 → $48
Current: $46.14
Upside: +4.03%
Nkarta
Mar 22, 2024
Downgrades: Outperform
Price Target: $13 → $16
Current: $6.21
Upside: +157.65%